Upgrade to SI Premium - Free Trial

JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

September 2, 2026 9:29 AM
JPMorgan analyst Chris Schott reiterated an Overweight rating and $1,400.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments